A law firm in Australia is preparing a fresh class action claim against Mesoblast that alleges misleading or deceptive conduct to investors and breaches of continous disclosure in the way in which the biotech promoted the prospects of its main product candidate, Remestemcel-L.
Specialist class action firm Phi Finney McDonald is preparing a class action against the $1.5 billion company led by founder and chief executive Silviu Itescu on behalf of investors who acquired shares between February 22, 2018 and December 17, 2020.
Silviu Itescu is chief executive and founder of Mesoblast, which is facing several class action lawsuits. Luis Ascui
Mesoblast is already facing multiple class action lawsuits in the US after being accused overseas of making false or misleading statements to investors, as well as failing to disclose material adverse facts about Remestemcel-L.
...looks like people have short memories.
and this release was what that sparked the frenzy all over again
UNITED STATES FOOD & DRUG ADMINISTRATION (FDA) NOTIFIES MESOBLAST THAT AVAILABLE CLINICAL DATA FROM PHASE 3 TRIAL APPEARSUFFICIENT TO SUPPORT BLA SUBMISSION FOR REMESTEMCEL-L IN CHILDREN WITH STEROIDREFRACTORY ACUTE GRAFT VERSUS HOST DISEASE (SR-a
Why is that word 'APPEAR' there and what is it meant to suggest?
Appear Sufficient is not the same as Deemed Sufficient.
Why do you still trust management with a dark history of alleged deceptive conduct?
I never want to discuss MSB here, I have had posted on this stock long ago, you can ask all the guys at the NewBeginning thread who had been involved with the stock back then.
